ALLvsMRSH
Allstate CorpvsMarsh & McLennan Companies Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Allstate Corp
$214.16
+3.37%
Marsh & McLennan Companies Inc
$174.01
-5.05%
60-day price, rebased to 100
Round-by-round
Valuation upside
+248.60% vs -5.10% to DCF fair value
Balance-sheet strength
Altman Z 2.29 vs 2.68
Fundamental quality
Piotroski 6.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 20.20 vs 28.90
60-day momentum
+8.53% vs -2.34% price return
Market-cap liquidity
$55.6B vs $84.5B
Verdict
Across6categories,MRSHtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onALLorMRSH
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.